Shanghai Haohai Biological Technology Co.,Ltd.’s Net Profit Dropped 47.1% in First Three Quarters of 2022

Shanghai Haohai Biological Technology Co.,Ltd. (上海昊海生物科技股份有限公司) (688366.SH) reported a net profit of 166.3 million yuan in the first three quarters of 2022, down 47.1% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 24.1% year-on-year.

At the end of the reporting period, it had 6.9 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 14.2%.